clinicalomicsprowebdirectory
News & Features
Topics
Precision Medicine
Translational Research
Molecular Dx
Informatics
Oncology
Patient Care
New Products
Magazine
Multimedia
Webinars
eBooks
Subscribe
Create a Free Account
Log In
Get Clinical OMICs Magazine
Get Clinical OMICs eNewsletters
Get the Clinical OMICs Mobile App
Get Clinical OMICs News from Alexa
Search
Advertise
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Lead Generation Campaigns
Email Nurture Campaigns
Custom Content Solutions
About Us
Contact Us
Mary Ann Liebert Publishers
Create a Free Account
Log In
Clinical OMICs – Molecular Diagnostics in Precision Medicine
News & Features
Translational Research
Precision Molecular Nabs Investment from ADDF for Development of More Effective…
Translational Research
Researchers Detail Mechanism for Clearing Misfolded Proteins at Root of Alzheimer’s…
Precision Medicine
Agendia Reports Positive Results in IMPACt Trial for Breast Cancer
Translational Research
Detailed Map of Breast Cancer Reveals the Effects of Mutations on…
Translational Research
Protein that Prevents Tau Clearance Linked to AD and Other Tau…
Topics
All
Precision Medicine
Translational Research
Molecular Dx
Informatics
Oncology
Patient Care
New Products
Translational Research
Precision Molecular Nabs Investment from ADDF for Development of More Effective…
Translational Research
Researchers Detail Mechanism for Clearing Misfolded Proteins at Root of Alzheimer’s…
Precision Medicine
Agendia Reports Positive Results in IMPACt Trial for Breast Cancer
Translational Research
Detailed Map of Breast Cancer Reveals the Effects of Mutations on…
Magazine
Magazine
Clinical OMICs Magazine Volume 7, Issue No. 1
Magazine
Clinical OMICs Magazine Volume 6, Issue No. 6
Magazine
Clinical OMICs Magazine Volume 6, Issue No. 5
Magazine
Clinical OMICs Magazine Volume 6, Issue No. 4
Magazine
Clinical OMICs Magazine Volume 6, Issue No. 3
Multimedia
All
Webinars
eBooks
Precision Medicine
From Bench to Clinic—The Potential of New Sequencing Tools
Precision Medicine
Mainstreaming Precision Oncology
eBooks
Better Understanding of Post-Translation Modifications Driving Innovation
Webinars
LeukoVantage: A Quest/QIAGEN Partnership Providing Clinical Insights Into Myeloid Malignancies
Subscribe
Create a Free Account
Log In
Get Clinical OMICs Magazine
Get Clinical OMICs eNewsletters
Get the Clinical OMICs Mobile App
Get Clinical OMICs News from Alexa
Home
Molecular Dx
Cancer Testing
Cancer Testing
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Cancer Testing
Precision Oncology Company OncoDNA Closes $20M Series B Financing
February 14, 2020
Cancer Testing
Illumina and Qiagen Enter 15-Year Diagnostics Partnership
October 8, 2019
Cancer Testing
FDA Expands Cologuard Cancer Test Approval to Younger People
September 24, 2019
Webinars
Cancer Gene Variant Detection Using a Pre-Optimized Sample to Report Workflow
August 21, 2019
Cancer Testing
ACMG Launches Evidence-Based Guidelines for Genetic, Genomic Testing
August 8, 2019
Cancer Testing
Biocept Intros Liquid Biopsy Kits for its ctDNA Platform
January 28, 2019
Cancer Testing
NeoGenomics to Acquire Genoptix for $140M in Cash and Stock
October 23, 2018
Cancer Testing
Invitae Acquires CancerGene Connect Developer
June 12, 2017
Cancer Testing
Ignyta to Use Angsana Cancer Panel in Registrational Trial of Anti-Tumor...
March 3, 2017
Cancer Testing
Study Identifies Barriers to Payer Coverage for Hereditary Cancer Panels
February 16, 2017
Load more
Scroll Up
We use cookies to give you a better experience on clinicalomics.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
![One of the major scientific crusades in oncology has been to identify and validate biomarkers associated with recurrent breast cancer. [iStock / royaltystockphoto]](https://www.clinicalomics.com/wp-content/uploads/2019/01/585-218x150.jpeg "Agendia Reports Positive Results in IMPACt Trial for Breast Cancer")
![Berg will partner with Massachusetts General Hospital and Brigham and Women's Hospital to study potential biomarkers for Alzheimer's and other neurodegenerative disorders from Harvard Biomarker Study biospecimens. [Source: ajcity.net]](https://www.clinicalomics.com/wp-content/uploads/2019/01/1397-218x150.jpeg "Protein that Prevents Tau Clearance Linked to AD and Other Tau Tangle Proteinopathies")
![Invitae says its acquisition of CancerGene Connect developer Ommdom is designed to expand its genome management support offerings for clinicians.[Ommdom]](https://www.clinicalomics.com/wp-content/uploads/2019/01/1126-324x160.png "Invitae Acquires CancerGene Connect Developer")
